Summary.-A comparison has been made of the immunological properties of CEA (carcinoembryonic antigen) and another perchloric acid-soluble macromolecule which occurs in colonic and certain other carcinomata and which is here termed CEX. By using a variety of antisera it was shown that the two substances share common antigenic groups as well as having characteristic ones of their own. These latter groups have enabled the preparation of (a) antisera which give a gel diffusion line only with CEA and (b) an antiserum which gives a line only with CEX. No immunological difference could be found between CEX and the NGP of Mach or the NCA of von Kleist and Burtin. CEX was found in foetal gut, in plasma and associated with CEA in virtually all the tissues and fluids in which the latter occurs; the two appear to go hand-in-hand and no proof was found that CEX is either less or more cancer specific than CEA-it is merely found in greater quantity; neither substance showed absolute cancer specificity. The usefulness of a radioimmunoassay for CEX is discussed, and also the possibility of interference by CEX in the radioimmunoassay for CEA. Evidence of two molecular species of CEA has been found.
first reported the existence of a glycoprotein antigen (CEA) in extracts of carcinomata of the colon and in the normal colon of human foetus of the first two trimesters of pregnancy, several authors have reported the existence of an associated protein antigen in these and other tissues which has been regarded, in general, as a more normal constituent of colon and certain other adult tissues. This protein has been given various names (NGP or normal glycoprotein, by Mach and Pusztaszeri, 1972 ; NCA or nonspecific crossreacting antigen, by von Kleist, Chavanel and Burtin, 1972; Kleinman, Harwell and Turner (1971) report a similar protein), and it is not certain that they all refer to the same substance, although this is likely because of its striking relationship with CEA. Indeed, its existence was suggested in Gold's original publication.
Our purpose was to study these two substances and their relationship further, using immunological methods. Particular attention was paid to the " associated" protein provisionally called CEX, since there was a possibility that a comparison of its concentration with that of CEA in a given extract or blood might enhance the value of the information given by CEA assay.
MATERIALS AND METHODS
Antisera.-Perhaps the most important part of this work was the preparation and comparison of various anti-CEA and anti-CEX (the CEA-associated protein) antisera. They were prepared by means of 3 injections of the antigen in complete Freund's adjuvant subcutaneously in the back, usually intrascapularly. The interval between the first and second injections wvas 2-4 weeks, and between the second and third 4-5 wecks.The first bleed was made about 2 weeks after the third injection. All bleeds wN-ere from the marginal ear vein of rabbits and from the jugular vein of goats. Occasionally a booster dose was given. The followNing antisera Awere made: (1) anti-saline extract of a human primary carcinoma of the colon made in 2 rabbits. The extract had 8 8 mg of protein per ml and each rabbit received 2-5 ml per injection; (2) anti-perchloric acid (PCA) extract of the same primary carcinoma of the colon in 2 rabbits. Each rabbit received 3-2 mg of the lyophilized extract per injection; (3) anti-PCA extract of a secondary colon carcinoma metastasis in the liver. The dose was 5 mg of the lyophilized extract per injection in 2 rabbits and 2-5 mg in another 2 rabbits; (4) anti-purified CEA prepared in 5 goats (one Gotenburg, 4 Irish mountain goats), each receiving 10 jug per injection according to Todd's method ; (5) A ntigens. The principal antigens used in vitro were the perchloric acid extract of colon cancer metastatis in the liver used in (3) above (to be referred to as PCAS), and the purified CEA preparation made by the method of Todd . This involved gel filtration of the PCA extract on Sepharose 4B and then on Sephadex G200, the active fractions being detected with anti-CEA (4); CEX was prepared similarly but came off the columns in a different peak and was detected by antiserum No. 3 (Turberville et al., 1973) . Plasma was concentrated for testing by precipitating 5 ml with 1 rnol/l perchloric acid, lyophilizing the water-dialysed supernatant and dissolving the resulting few mg of powder in 25 or 50 ,al of saline. In some instances, the lCD (immune complex development) technique (Darcy, 1972) 
RESULTS
Properties of the vario8usly-prepared antisera (Table 1) (1) Rabbit antisera to saline extracts of primary colon carcinoma. These antisera were unsatisfactorily weak, requiring concentration before use, probably because the original tumour extract was weak in CEX and particularly in CEA. After absorption they yielded a single line in gel diffusion with tumour extracts. When purified CEX and CEA were run simultaneously against them each antigen gave a single line which met the other in a reaction of identity.
(2) Rabbit antisera to PCA extracts of primary colon carcinoma. These proved identical to the above (Type 1) but were somewhat stronger. (3) Rabbit antisera to PCA extracts of secondary colon carcinoma.-These were the most interesting and useful antisera and have proved of value in estimating the relative amounts of CEA and CEX in column fractions using a modification of . After absorption they yielded two strong Ouchterlony lines with the extract which gave rise to them (PCAS), the slower-diffusing of which was shown to be CEA while the fastermoving line was ascribed to the unknown antigen which was called CEX (Fig. 1A) .
The second important property of these antisera was that their CEA and CEX lines both gave a reaction of identity with the single line obtained with purified CEA (Fig. IB) An early antiserum (3G 1) from one of the Irish goats gave a double CEA line (with both purified CEA and with PCAS) and which by its cross-reactions with others of these goat anti-CEA sera strongly suggested that they also would demonstrate this phenomenon given the correct antigen-antibody ratio ( Fig. 2A) . None of these antisera gave a CEX line. A later (purer) CEA preparation, made by " cutting " the column peaks of CEA more narrowly, showed the same 2 CEA lines but much closer together and with their positions reversed. This indicated that the faster diffusing component had been reduced in concentration.
(5) Rabbit anti-purified CEA. When bled 2 weeks after the last injection one of the resulting sera gave no line with CEX or CEA, but the second gave a line with CEA and not with CEX, thus appearing equivalent to the goat anti-CEA (Type 4).
(6) Rabbit anti-CEA gel precipitate lines. These antisera were weak. The stronger showed essentially a reaction of identity between CEX and CEA (which here gave a double line) but there was a faint CEA " spur " indicating some specific anti-CEA antibodies. The 2 CEA lines given by this antiserum were compared with those given by antiserum 3G1 (Type 4 above), but it was impossible to be certain that they were the same, even though there was an overall reaction of identity.
( (10) Goat anti-CEX (CEX purified by columnfractionation).-The only difference in procedure from No. 9 was that the goats received ,ug quantities of the antigen compared with mg amounts injected into the rabbits. Antisera from both goats gave several lines. In one goat these lines were found by absorption to be produced entirely by impurities in the CEX preparation. However, absorption of the antiserum from the other goat with plasma and normal colon left antibodies which reacted with CEX (to give a single line) but not with CEA at any concentration. The goal of producing a monospecific anti-CEX antiserum had apparently been achieved.
Absorption studies
These are summarized in Table II . Type 3 antiserum (anti-PCAS) was further absorbed with purified CEA, purified CEX and the crude PCAS. As would be expected, no lines were obtained with the antiserum after absorption with PCAS or CEA (which reacted with the anti-CEX antibodies (Fig. IB) . Absorption with purified CEX removed the CEX-line and It is apparent therefore that the outcome of the absorption can be determined by the selection of the absorbing "normal" extracts. It is also of some interest that we were unable to find a PCA extract of "normal" colon which was completely free of CEA and CEX. We could readily produce the picture obtained by Mach and Pusztaszeri (1972) by using an impure anti-CEA, i.e., one of our goat anti-CEA which contained some anti-CEX, before and after absorption with the "weak" colon extract (Fig. 2B) (Darcy, 1972) .
of CEA with massive amounts of anti-CEX weakened the CEA line. Absorption of CEX preparations with anti-CEA in massive amounts removed all CEX. This difference from the preceding experiment almost certainly reflects merely the relative strengths of the preparations. Absorption of the crude colonic carcinoma extract (PCAS) with anti-CEA removed the CEA line which it gave with antiserum Type 3 but left its CEX line. Massive absorption removed both lines. When it was absorbed with anti-CEX the reverse tended to happen but fell short of completion because of the weakness of the antiserum. Comparison of CEX with the (CEAassociated protein of other authors Fig. 4 shows an immunoelectrophoresis of CEA along with CEX using rabbit antiserum Type 1 (Table I ). The CEX gives a short arc which is entirely in the fl-region (it encircles the origin, mainly on its y-side). The CEA arc is a long one which extends from the fl-region to the x-region and there is a suggestion that it is a double-humped arc. These results were obtained on 1% I.D. Oxoid agar at pH 8 2. The same picture was, in its general features, obtained by others (Mach and Pusztaszeri, 1972; von Kleist et al., 1972 ).
An antiserum to her nonspecific crossreacting antigen (NCA) was kindly sent by Dr Sabine von Kleist. This gave a reaction of identity with our goat anti-CEX serum, using as antigen our purified CEX. Likewise, Dr Mach kindly sent Us a sample of his purified NCGP (normal glycoprotein). This gave a reaction of identity with our purified CEX using Type 10 antiserum (Fig. 3A) .
Occurrence of (EA and CEX in other tissues and fluids Our findings are shown in Table III Normal uirine after conceintrationi showed neither CEX nor CEA by immune diffusion, but urine from patients with bladder carcinoma or infections had varying amounts of CEX and CEA (Table IV) .
CEX and CEA were demonstrable in plasma (Table IVr and Fig 3B) . The amount of CEA estimated by the gel diffusion method was proportional to the amount estimated by radioimmunoassay of the same series of plasmas. CEX was dletectable in all cancer and normal plasma tested although sometimes in onlv trace amounts.
DISCUSSION
We have detected a CEA-associated antigen in varying amounts in a wide variety of tumours, including colonic and mammary carcinomata, normal" adult and foetal tissues. It has been provisionally named CEX to indicate its relationship with CEA. This relationship is best explained by the following model:
Let CEA be represented as C and CEX be represented as C--A -X where C represents antigenic groups common to both substances and A and X represent their specific distinguishing antigenic groups. Our numerous immunological findings appear to be explicable on this basis.
There can be little doubt that each substance has its own specific antigenic group(s). The production of specific antisera for each which failed to give a geldiffusion line with the other antigein, and the frequent occurrence of " spurring " with various anitisera seem to prove this.
The evidence for common antigenic group(s) comes mainly from reaction of identity " or ' partial identity". These were so nutmerotus and clear-cut (Fig. 1B) that they are unlikely to be accounted for by the only other plausible explanation, viz conitaminationi of the purified CEX by CEA and of the purified CEA by CEX. Contamination of our CEX by a small amount of CEA was known; similarly contamination of our puirified CEA by abouit 1 % of CEX could not be ruled out althoLugh a separate CEX line was not demonstrable using the most, sensitive ID.. methods. To invalidlate the reactions of identity by this explanation, it would be necessarv to assume a concentration of the contaminant sufficient to give a separate line which coincided perfectly with the existing single line, which did not exist in our preparations. Separate evidence comes from the antiserum Type 8 (Table I ) which was prepared with CEX, from which all traces of CEA had been removed by immunoabsorption and confirmed by radioimmunoassay. This antiserum gave a line with CEX and also with purified CEA, a finding which is difficult to explain other than by the presence of " common " antibody, i.e., anti-C. This antiserum would appear to contain anti-C and anti-X, since it showed a CEX " spur " but none for CEA. The other antisera can be similarly provisionally classified according to their reactions. Type-3 antiserum would appear to be anti-C, anti-A, since it failed to produce a CEX spur" but gave a CEA one; the CEX line which it gives must, on this basis, be produced by anti-C (Fig. IB) . The faster diffusion of the CEX line can be accounted for by its smaller molecular weight (Turberville et al., 1 973).
With materials from Mach and also from von Kleist, we have been able to show reactions of identity between NGP (Mach and Puisztaszeri, 1972) , NCA (von Kleist et al., 1972) and CEX, and they have similar electrophoretic patterns. Both NGP and NCA were isolated from pulmon- I15-7 ary tissue and until chemical identity has been firmly established, the name CEX is retained for our material.
Monospecific anti-CEA and CEX antisera could be raised in goats and rabbits by immunizing with ,ug doses of purified CEA and partly-purified CEX. Their monospecificity in gel diffusion suggests that they contained no anti-C, but the more sensitive method of massive absorption ( Table III ) strongly suggested that they contained small amounts of anti-C and possibly small amounts of antibody to the specific group of the other protein. That after a booster dose certain goats producing anti-CEA by this method gave a faint CEX line can be explained either by an increase in the amount of anti-C or by the appearance of anti-X (due to trace contamination) or to a combination of both. We were able to show that such antisera gave the appearance (Fig. 2B ) which suggested to Mach et al. (1972) that they should be absorbed with PCA extract of normal colon before being used in radioimmunoassay of CEA.
This raises the question of whether CEX can interfere in the radioimmunoassay of CEA. We have demonstrated that CEX is present in all human plasmas tested and probably in greater quantity than CEA. We have evidence that CEX has an antigenic group or groups in common with CEA. Yet we have observed that our CEX which had been further purified by treatment with an anti-CEA immunoabsorbant was registered as CEA-free by our radioimmunoassay, while it still gave a strong CEX line in gel diffusion. The answer must lie in the nature of the antiserum and the difference between the two tests. The antiserum used in our CEA radioimmunoassay was of the type which gave no CEX line and hence contained, at best, only trace amounts of antibody to CEX. This may be a sufficient explanation of the failure of CEX to interfere. There is also the possibility that the two tests differ in nature, that the radioimmunoassay, employing as it does high-affinity antibody (which may attach to the CEA molecule by both its " arms "), may The apparently paradoxical results of the " massive" absorptions shown in Table II can be adequately explained either by the presence of contamination of the absorbing antigen with the other antigen or to the common antigen group(s), or to both. When absorption failed to reach completion this was apparently because the technical limits of the test had been reached. The fact that purified CEA could be partly absorbed by anti-CEX suggests that this antiserum contained some anti-C and possibly some anti-A.
The phenomenon of a double CEA line (not CEX) produced early in immunization by at least one of the goats ( Fig. 2A) and one of the rabbits is of interest. It implies that CEA exists in (at least) two molecular forms, differing either in molecular weight or in antigenicity or both. That there is a size difference is suggested by the column fractionation evidence. That there may also be antigenic difference is suggested by the fact that neither line could prevent some anti-CEA antibody from passing through it and precipitating the other CEA behind it. It is of possible relevance that the immunoelectrophoresis arc for CEA showed a suggestion of a double-hump (Fig. 4) , i.e., of having a fast and a slow portion which were to some extent distinct.
Biologically the distribution of CEA and CEX is very similar. Neither is confined to neoplastic or foetal tissues although they are present in larger amounts in pathological tissues (Table  III) , thus confirming similar findings by Martin et al., 1972; Burtin et al., 1972 and Rosai, Tillach and Marchesi, 1972) . We have also found them in larger amounts in the body fluids of patients with a variety of tumours (Table IV) . Further, we have observed that their immunologically determined titre may be higher in autopsy than in surgical specimens, which suggests that autolysis may play a role in their recoverability.
Our findings of CEX in some tissues and fluids without accompanying CEA (Table III and IV) can be explained by the relative insensitivity of gel diffusion methods, which can detect only about 103 the amount measurable by radioimmunoassay and by the fact that CEX is nearly always present in greater amounts than CEA. Neither CEA nor CEX is thus cancer specific (Tables III and IV; Hall et al., 1972; Laurence et al., 1972) . Moreover, absorption of Type 4 antiserum (monospecific anti-CEA) with PCA extracts of normal colon did not leave a cancer-specific antiserum but, depending on the extract chosen, the resulting antiserum could have either no antibody activity or else have its anti-CEA activity slightly weakened. The absence of complete cancer specificity limits the differential diagnostic potential of CEA measurement in blood Laurence et al., 1972; LoGerfo et al., 1972; Zamchek et al., 1972) and in urine (Hall et al., 1972) .
However, it is possible that CEX may prove to be a clinically valuable tumourassociated molecule for which a radioimmunoassay capable of measuring it in small amounts should be established. In favour of this course of action is the finding that CEX appears to be no less specific than CEA and is always present in higher amounts in blood and usually in urine, so that it can be measured more readily. On this account, too, elevation of CEX level in body fluids may be detectable earlier.
On the other hand, its use as an aid to diagnosis or monitoring of therapy will depend on its levels in body fluids in association with inflammatory or regenerative disorders. Its higher level in normal tissue and plasma than CEA may mean that a wider range of values will be found in neoplastic and non-neoplastic disorders than occur with CEA.
